John-Paul Bonansinga MD received his medical degree in May 2022 from University of Texas Health & Science Center in San Antonio. He is the founder of Forge Applied Science & Technology (“F.A.S.T”) and led the rapid development of the company’s flagship point-of-care UV-C sterilization reactor during the first 16 months of the pandemic. The 3rd full engineering cycle for F.A.S.T’s pre-production protype was completed in only 3-months with successful manufacturing and assembly trials following in rapid sequence. He graduated from The University of Texas at Dallas with a BS in Neuroscience in 2016, and conducted undergraduate research in neurodegenerative disorders. Dr. Bonansinga is a combat veteran who was assigned to 1st Battalion, 75th Ranger Regiment from 2004 to 2008. He deployed extensively as a Foreign Service Officer in support of Department of Defense missions between 2009 and 2017.
Dr. Bonansinga conducted a comprehensive survey of MDI projects in Fall 2022 to identify medical, material, design, and sterile processing considerations for future technology transition and commercialization efforts.
Sequelae from a high spinal cord injury and subsequent hardware malfunction made personal health the primary focus of 2023. He consults (on a case-by-case basis) on topics ranging from anti-poaching to machine-human interfaces, and regularly allocates time to assist MDI teams. Dr. Bonansinga expects to return to a full-contact active lifestyle in late 2024.
S. Patent Application No. 18/092,701, Filed January 3, 2023, METHODS, SYSTEMS, AND APPARATUSES FOR DISINFECTING AND SANITIZING MATERIALS, John-Paul Bonansinga
PCT Patent Application No. PCT/US2021/040205, filed on July 1, 2021, METHODS, SYSTEMS, AND APPARATUSES FOR DISINFECTING AND SANITIZING MATERIALS, John-Paul Bonansinga
US Provisional Patent Application Serial Number 63/047,138, Filed July 1, 2020; “Device, Systems and Methods for Disinfecting and Sanitizing Materials”, John-Paul Bonansinga